Next Article in Journal
Besifloxacin Nanocrystal: Towards an Innovative Ophthalmic Preparation
Next Article in Special Issue
Optimization of a Novel Mandelamide-Derived Pyrrolopyrimidine Series of PERK Inhibitors
Previous Article in Journal
Cancer-Associated Membrane Protein as Targeted Therapy for Bladder Cancer
Previous Article in Special Issue
Bruton’s Tyrosine Kinase Inhibitor Zanubrutinib Effectively Modulates Cancer Resistance by Inhibiting Anthracycline Metabolism and Efflux
 
 
Review

Article Versions Notes

Pharmaceutics 2022, 14(10), 2220; https://doi.org/10.3390/pharmaceutics14102220
Action Date Notes Link
article xml file uploaded 18 October 2022 13:48 CEST Original file -
article xml uploaded. 18 October 2022 13:48 CEST Update https://www.mdpi.com/1999-4923/14/10/2220/xml
article pdf uploaded. 18 October 2022 13:48 CEST Version of Record https://www.mdpi.com/1999-4923/14/10/2220/pdf
article html file updated 18 October 2022 13:50 CEST Original file -
article html file updated 28 February 2023 18:42 CET Update -
article html file updated 1 March 2023 22:37 CET Update https://www.mdpi.com/1999-4923/14/10/2220/html
Back to TopTop